You have 9 free searches left this month | for more free features.

Gastric Secretion

Showing 1 - 25 of 6,914

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)

Not yet recruiting
  • Tuberculosis
  • Quantiferon Gold
  • +5 more
  • (no location specified)
Oct 27, 2023

Type 2 Diabetes, Morbid Obesity Trial in Tønsberg (Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy,

Active, not recruiting
  • Type 2 Diabetes
  • Morbid Obesity
  • Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy
  • +2 more
  • Tønsberg, Vestfold, Norway
    The Morbid Obesity Center, Vestfold Hospital Trust
Jun 1, 2022

Severe Obesity, Type 2 Diabetes in Obese Trial in São Paulo (Analyze basal expression incretin for immunolabeling and mRNA

Recruiting
  • Severe Obesity
  • Type 2 Diabetes Mellitus in Obese
  • Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells.
  • São Paulo, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Jul 7, 2022

Severe Obesity Trial in Hvidovre (Chenodeoxycholic Acid, Colesevelam)

Completed
  • Severe Obesity
  • Hvidovre, DK, Denmark
    Hvidovre University Hospital
Nov 25, 2020

Severe Obesity Trial in Hvidovre (Colesevelam, Chenodeoxycholic Acid, Water)

Completed
  • Severe Obesity
  • Hvidovre, Denmark
    Hvidovre University Hospital
Nov 25, 2020

Pulmonary Disease, Chronic Obstructive Trial in Overland Park (Danirixin, Omeprazole)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Overland Park, Kansas
    GSK Investigational Site
Apr 27, 2021

A New Method for Determining Gastric Acid Output UsingWireless

Completed
  • Gastric Acid Secretory Disorders
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Type2 Diabetes, Obesity, Morbid Trial in Hvidovre (Oral Glucose Tolerance Test, Hyperglycemic clamp with infusion of saline,

    Completed
    • Type2 Diabetes
    • Obesity, Morbid
    • Oral Glucose Tolerance Test
    • Hyperglycemic clamp with infusion of saline, GLP-1 or GIP
    • Hvidovre, Denmark
      Hvidovre University Hospital
    Mar 14, 2022

    Ketosis, Postprandial Hyperglycemia, Glucose Metabolism Disorders (Including Diabetes) Trial in Aarhus (3-hydroxybutyrate

    Recruiting
    • Ketosis
    • +2 more
    • 3-hydroxybutyrate (3-OHB)
    • Aarhus, Denmark
      Department of Endocrinology and Internal Medicine
    Jan 16, 2023

    Coronary Artery Disease Trial (Lansoprazole 15 mg)

    Not yet recruiting
    • Coronary Artery Disease
    • Lansoprazole 15 mg
    • (no location specified)
    Apr 6, 2023

    Bariatric Surgery Trial in Copenhagen (Placebo, Ghrelin)

    Recruiting
    • Bariatric Surgery
    • Placebo
    • Ghrelin
    • Copenhagen, Hvidovre, Denmark
      Department of Endocrinology, Hvidovre University Hospital
    Aug 15, 2022

    Effects of Bariatric Surgery on Insulin

    Completed
    • Obesity
    • +4 more
      • Phoenix, Arizona
        NIDDK, Phoenix
      Dec 14, 2019

      Bariatric Surgery Candidate, Glucose Metabolism Disorders Trial in Hvidovre (Ghrelin, Placebo)

      Recruiting
      • Bariatric Surgery Candidate
      • Glucose Metabolism Disorders
      • Ghrelin
      • Placebo
      • Hvidovre, Denmark
        Hvidovre Universitets Hospital
      Feb 3, 2022

      Marginal Ulcer Trial in Cleveland (Omeprazole 40 milligrams)

      Recruiting
      • Marginal Ulcer
      • Omeprazole 40 milligrams
      • Cleveland, Ohio
        Cleveland Clinic Foundation
      Mar 22, 2023

      NASH With Fibrosis, Weight Loss, Bariatric Surgery Candidate Trial in Roma (roux -en-y- gastric bypass, intensive life style

      Active, not recruiting
      • NASH With Fibrosis
      • +2 more
      • roux -en-y- gastric bypass
      • intensive life style modification
      • Roma, Italy
        Mingrone Geltrude
      Mar 22, 2023

      Dyspepsia Trial in Arlesheim (Amara drops)

      Recruiting
      • Dyspepsia
      • Amara drops
      • Arlesheim, Basel Land, Switzerland
        Klinik Arlesheim
      Sep 21, 2022

      Morbid Obesity Trial in Strasbourg (Endoscopic placement of additional sutures)

      Recruiting
      • Morbid Obesity
      • Endoscopic placement of additional sutures
      • Strasbourg, France
        Service de chirurgie digestive et endocrinienne, NHC
      Aug 18, 2022

      Obesity Trial in Nashville (benzocaine, )

      Enrolling by invitation
      • Obesity
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Mar 29, 2022

      Insulin Secretion Trial in Vellore (Ferrous sulphate)

      Completed
      • Insulin Secretion
      • Ferrous sulphate
      • Vellore, Tamil Nadu, India
        Christian Medical College
      Feb 11, 2022

      Stomach Tumor, Diabetes, Type 2 Trial in Daegu (long Roux limb Roux-en-Y reconstruction, long biliopancreatic limb Roux-en-Y

      Recruiting
      • Stomach Neoplasm
      • Diabetes Mellitus, Type 2
      • long Roux limb Roux-en-Y reconstruction
      • long biliopancreatic limb Roux-en-Y reconstruction
      • Daegu, Korea, Republic of
        Kyungpook National University Chilgok Hospital
      Feb 4, 2022

      Coronary Artery Disease, Gastroesophageal Reflux Disease Trial in Beijing (Indobufen and aspirin mimetic, Aspirin and indobufen

      Unknown status
      • Coronary Artery Disease
      • Gastroesophageal Reflux Disease
      • Indobufen and aspirin mimetic
      • Aspirin and indobufen mimetic
      • Beijing, China
        Beijing Anzhen Hospital, Capital Medical University
      Oct 14, 2019

      Visualizing Beta Cells After Bariatric Surgery

      Recruiting
      • Type 2 Diabetes Mellitus
      • 68Ga-exendin PET/CT
      • Arnhem, Gelderland, Netherlands
      • +1 more
      Jun 16, 2022

      Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone

      Active, not recruiting
      • Obesity
        • Nottingham, Notts, United Kingdom
          Queens Medical Centre
        Apr 5, 2022

        Gastric Emptying - Implications for Pathogenesis of Type 2

        Recruiting
        • Diabetes Mellitus, Type 2
          • Nottingham, Notts, United Kingdom
            David Greenfield Human Physiology Unit, University of Nottingham
          Apr 5, 2022